Press Releases
Turkish Cargo adds Quito the capital of Ecuador to its cargo flight network
Turkish Cargo, the fastest growing global air cargo carrier, continues to expand its flight network. The successful air cargo brand has just added Quito (UIO), the capital city of Ecuador, to the destinations with direct cargo flights.
The new addition...
Press Releases
INTERPHEX and Chemspec USA Announce New Show Dates For 2020
International Pharmaceutical Expo (INTERPHEX), the premier event where industry leaders and professional can experience pharma, bio and device innovation, technology and knowledge from development through commercialization all in one place, and Chemspec USA, dedicated exclusively to the fine and...
Press Releases
Bora Pharmaceuticals to acquire GSK Mississauga-based Facility
Bora Pharmaceuticals Co., Ltd and GSK announced they have entered into an agreement under which Bora Pharmaceuticals will acquire GSK's Mississauga, Ontario (Canada) facility. The GSK facility produces approximately 50 different products for over 100 markets worldwide and employs...
Press Releases
CVS Pharmacy signs agreement to acquire, rebrand and operate Schnucks Pharmacies
CVS Pharmacy, Inc., a subsidiary of CVS Health Corporation , and Schnucks announced that they have entered into a definitive agreement for CVS Pharmacy and certain of its subsidiaries to acquire Schnuck Markets Inc.'s retail and specialty pharmacy businesses.
Through...
IT & Data Management
J&J Launches Heartline , Virtual Study Designed to Explore if a New iPhone App and Apple Watch Can Help Reduce the Risk of Stroke
Johnson & Johnson announced that the Janssen Pharmaceutical Companies of Johnson & Johnson, in collaboration with Apple, opened enrollment for the Heartlineâ„¢ Study. The study is designed to explore if the Heartlineâ„¢ Study app on iPhone and heart health...
Clinical Trials
Bellerophon Announces Agreement with the FDA on its Planned Pivotal Phase 3 Study for the Treatment of Pulmonary Hypertension
Bellerophon Therapeutics, Inc , a clinical-stage biotherapeutics company, announced the successful completion of its End-of-Phase 2 Meetings with the U.S. FDA for INOpulse for the treatment of Pulmonary Hypertension associated with Pulmonary Fibrosis (PH-PF).
The Company, in consultation with the...
Press Releases
IBM Summit supercomputer joins fight against COVID-19
Technology has been at the center of scientific advances for decades. Just 16 years ago, IBM’s Blue Gene supercomputer debuted as the first supercomputer to break the petascale barrier and went on to play a critical role in sequencing...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.